ARTICLE | Product Development
Macrophage therapies to watch at AACR
BioCentury analyzes strategies targeting macrophages at AACR21
April 9, 2021 1:31 AM UTC
Macrophage cell therapies may make headlines this weekend as the first CAR macrophage data in an immunocompetent animal model read out at AACR, but the conference will also showcase a spate of other strategies designed to harness antitumor activity of the innate immune cells.
As the understanding of the immune system’s role in cancer has evolved past effector T cells, macrophages have emerged as one of the newest sources of immuno-oncology targets and therapies — a trend BioCentury has been tracking at the American Association for Cancer Research (AACR) meeting since 2019. ...